Senate Targets Chinese Biotech, Investments in Defense Bill
The US Senate has passed legislation that aims to restrict Chinese biotech companies from receiving federal funding and prohibit American investments in sensitive Chinese industries. This move is part of the broader defense bill, indicating the growing concerns over China's influence in critical sectors. The legislation targets specific Chinese biotech firms, potentially limiting their access to US government resources. Additionally, the bill seeks to limit American investments in Chinese industries deemed sensitive, such as those related to defense or emerging technologies. This legislative action reflects the ongoing tensions between the US and China, as the two nations navigate complex economic and geopolitical relationships. The passage of this bill highlights the US government's efforts to address perceived threats and protect its interests in strategic industries.
Source: For the complete article, please visit the original source link below.
